gad65 antigen therapy in recently diagnosed type 1 diabetes mellitus - The early detection of type 1 diabetes consumer needs diabetes mellitus and latent autoimmune diabetes in adults GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus N Engl J Med 366 2012 pp 433442 Crossref View in Scopus Google Scholar 18 DW Soeatmadji A Aulanniam F Fatah SB Sumitro The 65kD isoform of glutamic acid decarboxylase GAD65 is a major autoantigen in type 1 diabetes We hypothesized that alumformulated GAD65 GADalum can preserve betacell function in patients Intralymphatic administration of GADalum in type 1 diabetes long We hypothesized that alumformulated GAD65 GADalum can preserve betacell function in patients with recentonset type 1 diabetes Methods We studied 334 patients 10 to 20 years of age with type 1 diabetes fasting Cpeptide levels of more than 03 ng per milliliter 01 nmol per liter and detectable serum GAD65 autoantibodies Intralymphatic Injection of Autoantigen in Type 1 Diabetes The new engl and journal of medicine n engl j med 3665 nejmorg february 2 2012 433 original article GAD65 Antigen Therapy in Recently Diagnosed Type 1 Diabetes Mellitus Johnny Ludvigsson MD We studied 334 patients 10 to 20 years of age with type 1 diabetes fasting Cpeptide levels of more than 03 ng per milliliter 01 nmol per liter and detectable serum GAD65 autoantibodies GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus GAD65 Antigen Therapy in Recently Diagnosed Type 1 Diabetes Mellitus GAD65 antigen therapy in recently diagnosed type 1 diabetes melitus tipe satu adalah diabetes mellitus In DIAGNODE1 as described earlier 12 individuals 4 females and 8 males aged 1224 years with type 1 diabetes 6 months from diagnosis received a primary injection of 4 μg of GADalum Diamyd Medical Stockholm into an inguinal lymph node administrated by help of ultrasound technique followed by two booster injections of 4 μg each Antigenbased therapy requires adequate presentation to T cells GAD65 has been Ludvigsson J Krisky D Casas R et al GAD65 antigen therapy in recently diagnosed type 1 diabetes GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus Johnny Ludvigsson David Krisky Rosaura Casas Tadej Battelino Luis Castaño James Greening Olga Kordonouri Timo Otonkoski Paolo Pozzilli JeanJacques Robert Henk J Veeze Jerry Palmer Coauthors GAD65 Antigen Therapy in Recently Diagnosed Type 1 Diabetes Mellitus GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus The early detection of type 1 diabetes mellitus and latent autoimmune GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus DOI 101056NEJMoa1107096 Corpus ID 5669968 GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus articleLudvigsson2012GAD65AT titleGAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus authorJohnny Ludvigsson and David M Krisky and Rosaura Casas and Tadej Battelino and Luis Castano and James E Greening and Olga Kordonouri and Timo Otonkoski and GAD65 Antigen Therapy in Recently Diagnosed jagung manis boleh untuk penderita diabetes Type 1 Diabetes Mellitus
diabetes melitus risk factor
pengertian diabetes tipe 2
